BMX 8m Hill Accreditation Course for Development/Level 1 Coaches

AusCycling 8m Hill Acccreditation for AusCycling Development/BMXA Level 1 Coaches

Date and Time: 

Saturday 22nd January 2022  - before official training commences 

Time: 10.45am to 11.45am  

There will be 20 places available for registration. To register you must be an active Level 1/Development coach and demonstrate a need to obtain the 8m Hill accreditation in SA. Coaches who do not meet this requirement and register will be discounted from attending. 

Non-registered attendees will not be permitted to attend. 

Registration Closes: Wed 19th January 2022 or before if places are filled. 

Venue: Sam Willoughby BMX Facility - Glenthorne National Park-Ityamaiitpinna Yarta.

Cost: there is no cost to attend 

Provided: Course notes and attendance material will be provided electronially to registered participants. 

Assessment: A paper based quiz assessment will be taken at the end of the Course 

Bring:  Dress appropraite for the weather and wear covered shoes. Bring a notepad and pen/pencil for taking notes and to complete the quiz. 

You must be a financial member of  AusCycling to register and an accredited Level 1 or Development coach. 

For more information on the Course: Tammy Clarke 0404 883981/ tclarke@iprimus.com.au

For more information regarding course material: coaching@auscycling.org.au

____________________________________________________________________________

COVID-19 Statement

AusCycling is committed to delivering well-prepared courses in a safe, responsible and low risk manner. As such we will be asking participants to follow COVID-19 Safe Practices, such as:

• Donot attend the Course if you or someone in your family is feeling unwell. 
• Using alcohol based hand sanitisers
• Following good hygine practices
• Where possible maintaining physical distancing
• Minimising the sharing of equipment
• Covering coughs and sneezes with your elbow or a tissue.
• Follow the requirement of the South Australian Government in relaiton to COVID19.